Newsletter Archive

1. 09.18.26 -- When Should R&D Turn Back? 9/18/2026

   09/18/26 Life Science Leader Newsletter

2. 09.17.26 -- Your Collaborator: mAb Productivity And Robustness 9/17/2026

   09/17/26 Life Science Leader Newsletter

3. 09.16.26 -- Picking Biotech Winners Beyond The Hype With Olivier Litzka 9/16/2026

   09/16/26 Life Science Leader Newsletter

4. 09.15.26 -- Smarter Ways To Reduce Risk, Downtime, And Lifecycle Surprises 9/15/2026

   09/15/26 Life Science Leader Newsletter

5. 09.14.26 -- Humacyte To Begin Testing Bioengineered Blood Vessel In Heart Bypass Surgery 9/14/2026

   09/14/26 Life Science Leader Newsletter

6. 09.12.26 -- Life Science Leader Newsletter - Best Of August 9/12/2026

   09/12/26 Life Science Leader Newsletter

7. 09.11.26 -- Investigator Perspectives On What Matters In Obesity And GLP-1 Studies 9/11/2026

   09/11/26 Life Science Leader Newsletter

8. 09.10.26 -- Solving The Complexities of Rare Disease Clinical Development 9/10/2026

   09/10/26 Life Science Leader Newsletter

9. 09.09.26 -- Five Of The Most Useful Transformations In Modern Organic Synthesis 9/9/2026

   09/09/26 Life Science Leader Newsletter

10. 09.06.26 -- Stopping A Drug Development Program Sometimes Creates More Value Than Continuing 9/6/2026
    09/06/26 Life Science Leader Newsletter